Amanote Research
Register
Sign In
How Many Episodes of Hospital Care Might Be Prevented by Widespread Uptake of Pneumococcal Conjugate Vaccine?
Archives of Disease in Childhood
- United Kingdom
doi 10.1136/adc.88.10.859
Full Text
Open PDF
Abstract
Available in
full text
Categories
Child Health
Pediatrics
Perinatology
Date
October 1, 2003
Authors
E D G McIntosh
Publisher
BMJ
Related search
Use of Conjugate Pneumococcal Vaccine by United Kingdom Neonatal Intensive Care Units
Archives of Disease in Childhood: Fetal and Neonatal Edition
Pediatrics
Gynecology
Perinatology
Obstetrics
Medicine
Child Health
Adult Invasive Pneumococcal Disease Pre- And Peri-Pneumococcal Conjugate Vaccine Introduction in a Tertiary Hospital in Singapore
Journal of Medical Microbiology
Medicine
Microbiology
Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine
JAMA - Journal of the American Medical Association
Medicine
Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine Following Invasive Pneumococcal Disease
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Use of the New Pneumococcal Conjugate Vaccine in the USA
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Sinusitis and Pneumonia Hospitalization After Introduction of Pneumococcal Conjugate Vaccine
Pediatrics
Child Health
Pediatrics
Perinatology
Spatial Variability in the Persistence of Pneumococcal Conjugate Vaccine-Targeted Pneumococcal Serotypes Among Adults
Epidemiology
Epidemiology
Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis
Pediatrics
Child Health
Pediatrics
Perinatology
